Back to top

EyePoint to pay $4.6M to resolve False Claim Act allegations

In a posting on the U.S. Department of Justice’s Office of Public Affairs site, the agency said Eyepoint (EYPT) Pharmaceuticals has agreed to pay t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

EyePoint, Inc. (EYPT)